Not applicableLooking for participantsNCT06988605
What this trial is testing
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Who this might be right for
Atopic Dermatitis
Galderma R&D 1,000